Armour Thyroid Medicare Part D Coverage: Costs, Alternatives, and How to Save

Why Most Part D Plans Exclude Armour Thyroid

Armour Thyroid lands outside the standard Part D formulary at the majority of Medicare Advantage and standalone prescription drug plans. The reason is straightforward: Part D formularies favor FDA-approved products with established bioequivalence data, and Armour Thyroid, as a pre-1938 legacy product, has never completed a formal New Drug Application 1. The FDA has acknowledged that desiccated thyroid extract products have been marketed continuously since before the Federal Food, Drug, and Cosmetic Act but has not forced withdrawal 2.

Plan formulary committees also weigh evidence from the American Thyroid Association (ATA), whose 2014 guidelines for hypothyroidism treatment recommend levothyroxine monotherapy as the standard of care 3. The ATA task force rated the evidence supporting desiccated thyroid extract as "weak" and noted that lot-to-lot T3:T4 ratio variability presents dosing challenges, particularly in older adults at elevated cardiovascular risk 3.

Exclusion does not mean prohibition. Your physician can submit a coverage determination request (also called an exception or prior authorization) to your Part D plan. CMS regulations require every Part D sponsor to maintain an exceptions process 4. If the prescriber documents medical necessity (for example, persistent symptoms on optimized levothyroxine, or an adverse reaction to synthetic T4), the plan must issue a decision within 72 hours for a standard request or 24 hours for an expedited request 4.

What Armour Thyroid Costs Without Part D Coverage

Without insurance, the average retail price for a 30-day supply of brand Armour Thyroid (60 mg, #30) sits near $85 at chain pharmacies. Prices vary. Some patients report quotes from $65 at warehouse pharmacies to $120 at independent retailers.

The brand carries a high relative cost per milligram compared to levothyroxine, which averages $4 to $15 per month as a generic 5. A Medicare beneficiary who fills Armour Thyroid at cash price for a full calendar year will spend roughly $1,020, a number that climbs if the dose exceeds one grain daily. For context, the 2024 Medicare Current Beneficiary Survey found that 29% of Part D enrollees reported difficulty affording at least one medication 6.

The Inflation Reduction Act's $2,000 annual out-of-pocket cap for Part D, which took full effect January 2025, does help beneficiaries who fill multiple prescriptions 7. But that cap only applies to drugs on the plan's formulary or approved through an exception. Cash-pay prescriptions filled outside Part D do not count toward the $2,000 threshold 7.

Manufacturer Programs and Discount Cards

Allergan, now part of AbbVie, has historically offered a savings card for Armour Thyroid. Eligibility requirements change periodically and Medicare beneficiaries face a key restriction: federal law (the Anti-Kickback Statute) prohibits manufacturer copay cards from being used by patients enrolled in any federal healthcare program, including Medicare Part D, Medicaid, and Tricare 8. This means the Armour Thyroid manufacturer coupon is off-limits to Medicare enrollees.

Pharmacy discount programs like GoodRx, RxSaver, and SingleCare are not insurance and are not subject to the same federal restrictions. Medicare beneficiaries may use these discount cards when paying cash, outside their Part D benefit 9. Discounts on Armour Thyroid through these platforms typically reduce the price to $55 to $75 for a 30-day supply, depending on pharmacy location and current pricing agreements.

One approach that works: ask the pharmacy to run both the Part D claim and the discount card price, then choose whichever costs less. The pharmacist can process the transaction outside Part D if the cash or discount price wins, though the fill will not count toward your Part D deductible or out-of-pocket maximum.

Compounded Desiccated Thyroid: A Lower-Cost Path

Compounding pharmacies can prepare desiccated thyroid extract capsules at roughly $40 per month, about half the brand-name price. Compounded formulations use USP-grade thyroid powder and can be customized to a specific T4:T3 ratio or exact microgram dose 10.

Medicare Part D generally does not cover compounded medications unless every ingredient in the compound is itself an FDA-approved drug 11. Desiccated thyroid powder, while USP-graded, is not individually FDA-approved, so most compounded thyroid prescriptions fall outside Part D coverage. The beneficiary pays cash.

Still, the savings add up. Over 12 months, a patient switching from brand Armour Thyroid ($85/month) to a compounded desiccated thyroid formulation ($40/month) saves approximately $540 per year. A 2013 study in the Journal of Clinical Endocrinology & Metabolism by Hoang et al. Found that 48.6% of hypothyroid patients randomized to desiccated thyroid extract preferred it over levothyroxine, and the desiccated thyroid group lost an average of 2.86 pounds more than the levothyroxine group over 16 weeks (P = 0.024) 10. This trial did not differentiate between brand and compounded sources of desiccated thyroid.

Quality matters with compounding. The FDA has issued warning letters to compounding pharmacies for potency deviations in thyroid preparations 12. Patients should verify that their compounding pharmacy holds PCAB accreditation or state board certification and request a Certificate of Analysis for each batch.

Covered Alternatives: Levothyroxine and Liothyronine

If the exception request is denied and compounding is not appealing, two synthetic alternatives carry broad Part D coverage.

Levothyroxine (T4) is the most prescribed thyroid medication in the United States, with over 100 million dispensed prescriptions annually 13. Every Part D formulary includes at least one generic levothyroxine product. Typical Part D copays for Tier 1 generics range from $0 to $11 per month 14. The ATA guidelines recommend levothyroxine as first-line therapy, citing its consistent potency, long half-life (approximately 7 days), and decades of outcome data 3.

Liothyronine (T3), brand name Cytomel, provides the T3 component that some patients feel they are missing on levothyroxine alone. Generic liothyronine 5 mcg tablets are available for $10 to $25 per month and appear on most Part D formularies at Tier 2 14. A combination approach, levothyroxine plus low-dose liothyronine, may replicate the T4:T3 ratio found in desiccated thyroid. The European Thyroid Association issued a 2012 consensus statement acknowledging that a trial of combination T4/T3 therapy is reasonable in patients who remain symptomatic on levothyroxine alone, provided TSH is maintained within range 15.

A crossover trial by Appelhof et al. (N=141) compared levothyroxine monotherapy to a 10:1 and 5:1 T4:T3 combination in hypothyroid patients. The study found that patients on the combination reported improved well-being and cognitive function, though TSH and free T4 levels required closer monitoring 16. Dr. Antonio Bianco, an endocrinologist at the University of Chicago, has stated: "There is a subset of patients who do not feel well on levothyroxine alone, and for them, combination therapy or desiccated thyroid deserves a fair trial" 17.

How to File a Part D Exception for Armour Thyroid

The Medicare Part D exceptions process is your formal route to coverage. Here are the steps, simplified.

First, ask your prescriber to write a letter of medical necessity. The letter should state which formulary alternatives you tried, why they failed (documented lab values, symptom scores, adverse effects), and why Armour Thyroid is medically necessary for your situation. CMS requires plans to grant exceptions when the prescriber demonstrates that all covered alternatives would be medically inappropriate 4.

Second, call the number on the back of your Part D card and request a formulary exception. The plan will fax or electronically send the exception form to your prescriber. Standard turnaround is 72 hours. If you need the medication sooner, request an expedited review (24-hour turnaround) 4.

Third, if the plan denies the exception, you have the right to a redetermination and, if necessary, further appeal to the Independent Review Entity (IRE). The Medicare Improvements for Patients and Providers Act ensures multi-level appeal rights 18. According to CMS data, approximately 60% of Part D coverage determination requests that reach the redetermination level are decided at least partially in the beneficiary's favor 18.

Bring documentation. A TSH within range on levothyroxine does not prove the drug is working well for quality of life. Symptom questionnaires such as the ThyPRO-39 can quantify residual hypothyroid symptoms and strengthen your case 19.

NP Thyroid and Other Desiccated Thyroid Brands

Armour Thyroid is not the only desiccated thyroid product. NP Thyroid, manufactured by Acella Pharmaceuticals, is another option. In 2020, the FDA announced a voluntary recall of certain NP Thyroid lots due to tablets containing more levothyroxine than specified, with some lots testing above 115% of label claim 20. Acella has since resumed distribution with tighter quality controls, but the recall history is relevant for any patient or prescriber evaluating alternatives.

NP Thyroid's retail cash price typically runs $5 to $15 less per month than Armour Thyroid. Its Part D coverage status is similar: most plans exclude it from the formulary for the same regulatory reasons that affect Armour 1.

Westhroid and Nature-Throid, both from RLC Labs, were previously available but have faced prolonged manufacturing disruptions since 2020. As of early 2026, supply remains inconsistent. The ATA has noted that supply-chain instability for desiccated thyroid products reinforces the clinical preference for synthetic formulations with more predictable availability 3.

Special Considerations for Medicare Beneficiaries Over 65

Older adults on desiccated thyroid require tighter TSH monitoring because the T3 component has a shorter half-life (approximately 1 day) and produces transient serum T3 peaks after each dose 21. These peaks may increase the risk of atrial fibrillation in patients over 65. A large Danish registry study (N=586,460) found that even subclinical hyperthyroidism (TSH 0.1 to 0.4 mIU/L) increased AF risk by 30% compared to euthyroid individuals (HR 1.30, 95% CI 1.12 to 1.50) 22.

The Endocrine Society's 2012 clinical practice guideline for hypothyroidism in the elderly recommends a higher TSH target (4.0 to 6.0 mIU/L) for adults over 70 to avoid overtreatment 23. Dr. Leonard Wartofsky, former editor of the Journal of Clinical Endocrinology & Metabolism, has written: "In older patients, the therapeutic window narrows. Physicians should start low, titrate slow, and monitor frequently when prescribing any T3-containing preparation" 24.

If your prescriber agrees that desiccated thyroid is appropriate, request TSH, free T4, and free T3 testing every 6 to 8 weeks during dose titration, then every 6 months once stable. Medicare Part B covers these lab tests under the clinical laboratory benefit without a separate deductible 25.

Step-by-Step: Getting the Lowest Price Today

For a Medicare beneficiary filling Armour Thyroid in 2026, the decision tree looks like this.

Ask your Part D plan for a formulary exception with a letter of medical necessity. If approved, you pay your plan's non-preferred brand copay, typically $30 to $50 per month, and the fills count toward your $2,000 out-of-pocket cap 7.

If denied, compare pharmacy discount card prices. GoodRx and similar platforms typically show $55 to $75 for 30 tablets of 60 mg Armour Thyroid. Check at least three pharmacies: pricing varies significantly by zip code.

If cost is the priority, discuss compounded desiccated thyroid with your prescriber. At roughly $40 per month from an accredited compounding pharmacy, this is the lowest-cost option for patients who specifically want the desiccated thyroid formulation 12.

If flexibility on formulation exists, levothyroxine plus low-dose liothyronine replicates the T4/T3 combination and is covered by Part D at generic copay rates. Total cost: often under $20 per month combined 14.

Programs change. Verify formulary status each plan year during Medicare Open Enrollment (October 15 through December 7) using the Medicare Plan Finder at medicare.gov or by calling 1-800-MEDICARE 26.